Target intelligence / Profile preview

Non-specific physiological targets

Molecular classification
Other
01

Overview

Non-specific physiological targets represent a classification for therapeutic agents that do not rely on binding to a specific protein, such as a receptor, enzyme, or ion channel, to exert their effects. Instead, these agents work through fundamental physical or chemical processes, such as the neutralization of hydrochloric acid in the stomach by antacids or the alteration of osmotic pressure in the renal tubules by diuretics like mannitol (StatPearls, 2023). Common examples include aluminum hydroxide and activated charcoal, which act on the physiological environment or chemical entities rather than a discrete molecular macromolecule (ChEMBL, 2024). Because this term describes a functional outcome or a general physiological state rather than a specific gene product, it is often classified as a non-specific or 'incorrect' target in pharmacological databases (DrugBank, 2024). These agents are vital for treating conditions such as metabolic acidosis, cerebral edema, and acute poisoning, where systemic or localized physical changes are required. However, due to their broad nature, they are not suitable for precision medicine approaches or structure-based drug design (PubMed, 2022). Monitoring the efficacy of these agents typically involves measuring systemic parameters like pH or osmolality rather than specific molecular biomarkers.

Other names
Non-specific targetsPhysiological factorsNon-molecular targetsGeneral physiological effects
02

Mechanism of action

Drugs in this category act through non-receptor-mediated pathways, including chemical neutralization of acids, creation of osmotic gradients to shift fluid balance, or physical adsorption of toxins within the gastrointestinal tract.

03

Biological functions

Acid-base homeostasisOsmotic regulationPhysical adsorptionHomeostasis
04

Disease associations

Gastrointestinal disorderCerebral edemaPoisoningConstipationAcidosisAlkalosis
05

Safety considerations

Electrolyte disturbancesAcid-base imbalanceInterference with absorption of other medicationsSystemic accumulation in renal impairment
06

Interacting drugs

Aluminum hydroxide

5 more in the full profile.

07

Biomarkers

Gastric pHSerum osmolalityStool consistencyElectrolyte levels

Beyond the preview

Go deeper on Non-specific physiological targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific physiological targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call